Transcriptomic and epigenomic dynamics associated with development of human iPSC-derived GABAergic interneurons
George Andrew S Inglis1, Ying Zhou2,3, Dillon G Patterson4
1Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Human Molecular Genetics
|August 15, 2020
Summary
This study maps gene expression and chromatin changes during GABAergic interneuron (GIN) development. It identifies key transcription factors and regulatory networks essential for GIN function and potential therapeutic targets.
Area of Science:
- Neuroscience
- Developmental Biology
- Genomics
Background:
- GABAergic interneurons (GINs) are crucial for maintaining neuronal excitability and network activity.
- Dysfunction in GINs is implicated in neurological disorders like schizophrenia and epilepsy.
- Understanding GIN development is key to identifying therapeutic targets.
Purpose of the Study:
- To investigate temporal gene expression and chromatin accessibility changes during human GIN development.
- To identify transcription factors and regulatory networks governing GIN differentiation.
- To provide a resource for studying molecular mechanisms of GIN function.
Main Methods:
- Transcriptomic and epigenomic analyses were performed on human induced pluripotent stem cell-derived neurons.
- Samples were collected at 22, 50, and 78 days post-differentiation.
- Differentially accessible regions (DARs) and enriched transcription factor families were identified.
Main Results:
- 13,221 differentially accessible chromatin regions were identified, correlating with temporal gene expression changes.
- Specific transcription factor families showed increasing enrichment during GIN differentiation.
- These findings highlight regulatory networks driving GIN development.
Conclusions:
- The study provides a comprehensive dataset on molecular changes during GIN development.
- Identified regulatory networks offer insights into GIN functionality.
- This resource can advance research into GIN-associated disorders and therapeutic strategies.
Related Concept Videos
Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K
Somatic to iPS Cell Reprogramming
2.5K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.5K


